CNN’s Soledad O’Brien took an unusual tack in a recent story by noting that drug company’s research and development spending could be affected by Wal-Mart forcing more generic drugs, noted Ken Shepherd of the Business & Media Institute.
“On the February 20 ‘In the Money,’ panelist Jennifer Westhoven repeated the claim from liberal Tufts University’s Dr. Jerome Kassirer that about 90 percent of pharmaceutical marketing ‘goes to wining and dining doctors.’ Westhoven and her panelists ignored the fact that in 2003, the amount spent on direct-to-consumer advertising by members of PhRMA, a pharmaceutical industry group, amounted to only one-tenth of that spent on research and development.
Kassirer even took issue with free drug samples that drug company representatives often leave for physicians to give to patients on a trial basis. ‘Any time you use those free samples, then the doctor gets used to using that particular drug and that raises the cost of care,’ Kassirer complained.
“None of the CNN crew paused to question Kassirer’s logic or whether his opposition to free samples might hurt patients unable to afford prescription medicine.”
Read more here.
Crain's Chicago Business is a leading source of news, analysis, and information on the business,…
Emma Sandler has been hired as associate editor at Agenda, a publication under the FT…
Cablefax Daily interviewed Fox Business Network anchor Liz Claman on her induction into the Cable Hall…
BBC News has hired Charlotte Edwards as a reporter covering money, work and technology. She previously was…
Reuters has promoted Hatem Maher to deputy breaking news editor for the Middle East. Maher has been…
Canada's Financial Post has hired Ben Cousins as a senior editor. He has been working as a…